- Home
- PGC vs ABSI Comparison
PGC vs ABSI Comparison
Compare PGC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGC | ABSI |
|---|---|---|
| Founded | 1921 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.7M | 997.8M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PGC | ABSI |
|---|---|---|
| Price | $44.32 | $8.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $40.50 | $6.96 |
| AVG Volume (30 Days) | 127.0K | ★ 2.7M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | ★ 13.51 | 10.64 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $282,995,000.00 | $4,534,000.00 |
| Revenue This Year | $32.39 | $215.96 |
| Revenue Next Year | $12.64 | $319.10 |
| P/E Ratio | $27.02 | ★ N/A |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $24.71 | $2.24 |
| 52 Week High | $49.14 | $12.06 |
Technical Indicators
Market Signals| Indicator | PGC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.94 | 48.24 |
| Support Level | $43.44 | $8.55 |
| Resistance Level | $47.47 | $10.03 |
| Average True Range (ATR) | 0.92 | 0.57 |
| MACD | -0.14 | -0.06 |
| Stochastic Oscillator | 4.35 | 16.22 |
Price Performance
Historical ComparisonAbout PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.